(Total Views: 176)
Posted On: 01/28/2020 12:40:42 PM
Post# of 127208

$INCY News Article - Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic Dermatitis https://marketwirenews.com/news-releases/incy...30153.html


My Twitter: WhyteStocks